A revolutionary HIV treatment may be on the horizon. GAMMORA, developed by Code Pharma, has demonstrated the ability to eliminate HIV-infected cells without harming healthy ones—a major breakthrough in the search for a cure. Phase 2 clinical trials have shown a significant reduction in viral load when GAMMORA is combined with antiretroviral therapy. The study was recently referenced on the South Florida Sun-Sentinel website.
“We have proven that HIV-infected cells can be eliminated,” says Code Pharma CEO Zyon Ayni. With larger trials underway in multiple countries, this innovative treatment could change the future of HIV care. While further research and regulatory approval are needed, GAMMORA brings renewed hope for millions worldwide.